NASDAQ · Analyst Forecast

Medline Inc. (MDLN) Stock Forecast & Price Target

$37.68 NASDAQ: MDLN Market Cap $33.11B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Medline Inc. (MDLN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Medline Inc., analysts forecast revenue rising from $28.16B in 2025 to $42.38B in 2030; the average estimate for 2030 earnings per share is $2.31; with published estimates ranging from $2.28 to $2.34; 21 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$37.68
Consensus targetThe average of the price targets analysts have published.$44.20
Median targetThe middle target, less affected by a single outlier.$44.00
Highest targetThe most optimistic published target.$55.00
Lowest targetThe most pessimistic published target.$37.00
Difference from priceHow far the consensus target sits from today’s price.+17.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$28.15B$28.16B$28.17B16
2026$31.21B$31.38B$31.51B18
2027$33.61B$33.89B$34.19B20
2028$35.78B$36.55B$37.36B21
2029$39.07B$39.44B$39.83B10
2030$41.99B$42.38B$42.79B10

Earnings per share forecast

YearLowAverageHighAnalysts
2025$1.16$1.20$1.3816
2026$1.40$1.54$1.6418
2027$1.40$1.56$1.6920
2028$1.38$1.77$2.0221
2029$2.03$2.05$2.0810
2030$2.28$2.31$2.3410

Medline Inc. (MDLN) forecast — frequently asked questions

What is the analyst price target for Medline Inc.?

Analysts covering Medline Inc. (MDLN) have a consensus price target of $44.20, 17.3% above the current price of $37.68. Published targets range from $37.00 to $55.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Medline Inc.'s earnings?

The average analyst estimate for Medline Inc. (MDLN) earnings per share in 2030 is 2.31, with individual estimates between 2.28 and 2.34.

How much revenue is Medline Inc. expected to make?

Analysts forecast Medline Inc. (MDLN) revenue of $42.38B in 2030, based on 10 published estimates.

How many analysts cover MDLN?

21 analysts contribute estimates for Medline Inc. (MDLN). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Instruments & Supplies stocks

BDX forecastWST forecastSOLV forecastBAX forecastCOO forecastRGEN forecastAVTR forecastATR forecastBLCO forecastTFX forecastAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.